PHOENIX, May 23, 2024
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that
Joel Fruendt, Chief Executive
Officer, and Tom Chesterman, Chief
Financial Officer, will participate in a webcasted presentation and
host one-on-one meetings with investors at the Lytham Partners
Spring 2024 Investor Conference, taking place virtually on
Thursday, May 30, 2024.
Company Webcast
The webcasted presentation will take place at 11:45am ET on
Thursday, May 30, 2024. The webcast
can be accessed by visiting the conference home page at
https://lythampartners.com/spring2024/ or directly at
https://wsw.com/webcast/lytham11/snes/2110185. The webcast
will also be available for replay following the event.
1×1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1×1@lythampartners.com or register for
the event at https://lythampartners.com/spring2024invreg/.
About SenesTech
We are committed to improving the health of the world by
humanely managing animal pest populations through our expertise in
fertility control. We invented ContraPest, the only U.S.
EPA-registered contraceptive for male and female rats, as well as
Evolve and Evolve Mouse, EPA-designated minimum risk contraceptives
for rodents, reflecting our mission to provide products that are
proactive, safe and sustainable. ContraPest and Evolve fit
seamlessly into all integrated pest management programs,
significantly improving the overall goal of effective pest
management. We strive for clean cities, efficient businesses and
happy households – with a product designed to be humane, effective
and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
Forward-looking statements include statements concerning results
of operations and financial performance; the Company's strategy and
target marketing and markets; continuing the Company's vision;
expected benefits of the Company's initiatives and continuation of
those initiatives; deployment of the Company's product; the
continuation or expansion of the use of ContraPest; demand for
ContraPest; the Company's expectation regarding costs, expenses and
cash and continuing its cost improvement plan; future financial
results; and the Company's execution of its strategic business
plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-spring-2024-investor-conference-on-may-30-2024-302153450.html
SOURCE SenesTech, Inc.